There are 2949 resources available
LBA26 - Phase II study of the oral HIF-2α inhibitor MK-6482 for Von Hippel-Lindau (VHL) disease-associated clear cell renal cell carcinoma (ccRCC): Update on RCC and non-RCC disease
Presenter: Ramaprasad Srinivasan
Session: Mini Oral - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
703MO - An integrated study of spatial dynamics and genomic alterations in renal cell carcinoma evolution
Presenter: Yue Zhao
Session: Mini Oral - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
LBA27 - Phase II multicenter, randomized study to evaluate efficacy and safety of avelumab with gemcitabine/carboplatin (CG) vs CG alone in patients with unresectable or metastatic urothelial carcinoma (mUC) who are ineligible to receive cisplatin-based therapy
Presenter: Begona Perez Valderrama
Session: Mini Oral - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
704MO - Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone with 1L chemotherapy (CTx) for advanced urothelial carcinoma (UC): Subgroup analyses from JAVELIN Bladder 100
Presenter: Petros Grivas
Session: Mini Oral - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
705MO - Sitravatinib (sitra) in combination with nivolumab (nivo) demonstrates clinical activity in checkpoint inhibitor (CPI) naïve, platinum-experienced patients (pts) with advanced or metastatic urothelial carcinoma (UC)
Presenter: Pavlos Msaouel
Session: Mini Oral - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
706MO - Association between human papillomavirus (HPV) infection and outcome of perioperative nodal radiotherapy for penile carcinoma
Presenter: Andrea Necchi
Session: Mini Oral - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
707MO - Longitudinal cohort analysis of patients with metastatic penile cancer treated in a large quaternary academic centre
Presenter: Wing Kin Liu
Session: Mini Oral - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
86MO - Personalized molecularly matched therapies for carcinomas of unknown primary is associated with improved outcomes
Presenter: Jacob Adashek
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
87MO - Assessing tumour fraction of CSF cfDNA improves diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis (BCLM)
Presenter: Amanda Fitzpatrick
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
LBA10 - Critical role of eosinophils during response to immune checkpoint blockade in breast cancer and other cancer types
Presenter: Leonie Voorwerk
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast